In our study, lymph node status turned out to be the most important predictive factor, with a significantly higher response rate in N0 tumours as compared with N1–2 tumours (47 vs 9%; P=0.004), independently of treatment and TS status. This evidence concerns the gene TYMS and neoplasm.